FMR1 and fragile X syndrome: The results presented in this study, may have clinical relevance, as a detailed molecular diagnosis (including information about methylation status, FMR1mRNA and FMRP levels) could provide additional information and guide to clinicians and expectations for the family of a patient with FXS.